Results 231 to 240 of about 21,604,258 (289)

Caregiver support in patients with plasma cell dyscrasias: A novel single‐item pilot measure of caregiver availability: Results from a survey of >1000 patients

open access: yesBritish Journal of Haematology, EarlyView.
Summary Treatment for plasma cell dyscrasias imposes burdens on patients and caregivers, particularly for cellular therapies. Traditional social determinants of health may not capture caregiver availability. We conducted a cross‐sectional survey through HealthTree.
Ghulam Rehman Mohyuddin   +12 more
wiley   +1 more source

The role of neuroimaging in neurotoxicity after chimeric antigen receptor T-cell therapy. [PDF]

open access: yesTher Adv Neurol Disord
Lasocki A   +3 more
europepmc   +1 more source

Efficacy and safety of chimeric antigen receptor T-cell therapy in primary central nervous system lymphoma: a systematic review and meta-analysis. [PDF]

open access: yesImmunotherapy
Al-Mashdali AF   +7 more
europepmc   +1 more source

Cytokine-Engineered Chimeric Antigen Receptor-T Cell Therapy: How to Balance the Efficacy and Toxicity. [PDF]

open access: yesAdv Sci (Weinh)
Zhang X   +7 more
europepmc   +1 more source

Independent validation of the International Metabolic Prognostic Index (CAR‐IMPI) in patients with aggressive diffuse large B‐cell lymphoma treated with CAR‐T

open access: yes
British Journal of Haematology, EarlyView.
Eugenio Galli   +11 more
wiley   +1 more source

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges

open access: yesBritish Journal of Pharmacology, EarlyView.
This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu   +6 more
wiley   +1 more source

Correction to: Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapy. [PDF]

open access: yesInt J Hematol
Tashiro Y   +11 more
europepmc   +1 more source

Outcomes for post‐transplant relapsed acute lymphoblastic leukaemia in the era of novel therapies: A retrospective multicentre UK study

open access: yes
British Journal of Haematology, EarlyView.
Alexandros Rampotas   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy